Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2013 by Gruppo Italiano Studio Linfomi.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Gruppo Italiano Studio Linfomi
ClinicalTrials.gov Identifier:
NCT01686386
First received: July 31, 2012
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)